Oouchi, Y.; Watanabe, M.; Ida, Y.; Ohguro, H.; Hikage, F.
Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners. Int. J. Mol. Sci. 2021, 22, 7335.
https://doi.org/10.3390/ijms22147335
AMA Style
Oouchi Y, Watanabe M, Ida Y, Ohguro H, Hikage F.
Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners. International Journal of Molecular Sciences. 2021; 22(14):7335.
https://doi.org/10.3390/ijms22147335
Chicago/Turabian Style
Oouchi, Yuika, Megumi Watanabe, Yosuke Ida, Hiroshi Ohguro, and Fumihito Hikage.
2021. "Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners" International Journal of Molecular Sciences 22, no. 14: 7335.
https://doi.org/10.3390/ijms22147335
APA Style
Oouchi, Y., Watanabe, M., Ida, Y., Ohguro, H., & Hikage, F.
(2021). Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners. International Journal of Molecular Sciences, 22(14), 7335.
https://doi.org/10.3390/ijms22147335